Skip to main content

US agreement clarifies the use of stem cells in research

Agreement enables basic stem cell research to continue but bans diagnostic or therapeutic applications.

Written byTabitha Powledge
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00

MARYLAND – Access for US scientists to human embryonic stem cells appears to be improving thanks to an agreement negotiated earlier this month by the National Institutes of Health (NIH) and the WiCell Research Institute, Inc., Madison, Wisconsin — a non-profit organization established in October 1999 to advance research in the area of stem cells. The agreement sets out the terms under which researchers can obtain and use the five WiCell cell lines developed before 9 August 2001, which US President George W. Bush has said are ethically acceptable for federally funded research. The need for the agreement is demonstrated by the fact that WiCell is currently receiving 10 to 15 requests for the cell lines every day.

The new agreement specifies that the cells can be used only for non-commercial research and teaching. But the NIH, not WiCell, will retain ownership of any new intellectual property arising from that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo